Evaluatie van het myAirCoach zelf-management ondersteuningssysteem voor mensen met astma in vergelijking met gebruikelijke zorg: een pragmatisch gerandomiseerd onderzoek (myAirCoach: evaluation campaign).

DESIGN

Multi-centre, pragmatic randomized control trial

AIMS

To assess the myAirCoach system in a real life environment and determine whether it provides clinical benefit (improvements in asthma control) to patients with asthma.

OUTCOME MEASURES

Primary: Asthma Control (assessed through the ACQ)

Secondary: Lung function, asthma exacerbation, quality of life, Symptoms, costs

POPULATION

Maximal 60 subjects in the Netherlands, minimal 30 subjects in the UK, 90 subjects in total

ELIGIBILITY

Adult patients with uncontrolled asthma

TREATMENT

myAirCoach intervention

DURATION

3-9 months (variable follow-up length); A sequential phased study so that patients will therefore be involved for a minimum 3 months, up to a maximum 9 months

Self-management support by the myAirCoach system as an adjunct to usual care improves asthma control in patients with asthma, compared to usual care.

Type of study: Multi-centre, pragmatic randomized controlled trial, in which participants will be randomized in a 1:1 ratio to myAirCoach self-management support as an adjunct to usual care (myAirCoach group) or to usual care alone (usual care group).

Duration: 3-9 months (staggered enrolment with variable follow-up duration). A sequential phased study so that patients will therefore be involved for a minimum 3 months, up to a maximum 9 months.

Usual care group

Patients in the usual care group will be provided with regular (face-to-face) care with their health care professionals.



myAirCoach group

In addition to usual care patients in the myAirCoach group will be provided with self-management support via the myAirCoach system. This system consists of the several devices and mHealth and web-applications for patients as well as a web-application for health care professionals.